CGNT Cogentix Medical, Inc. gains 27% Aug 10, 2017

Cogentix Medical, Inc., a medical device company, designs, develops, manufactures, and markets products for the urology market and flexible endoscopy. The company principally offers Urgent PC neuromodulation system for the overactive bladder and associated symptoms of urge incontinence, urinary urgency and urinary frequency; and Macroplastique implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. It also provides EndoSheath system, which combines endoscopic technology with a sterile and disposable microbial barrier for flexible endoscopy. In addition, the company offers Macroplastique products for treatment of vesicoureteral reflux; PTQ Implants, which provide a minimally-invasive, soft-textured permanent implant for treatment of fecal incontinence; Urgent PC System for the treatment of fecal incontinence; and VOX Implants, a silicone elastomer bulking material for vocal cord rehabilitation applications, as well as distributes wound care products. The company sells its products primarily to urologists, urogynecologists, and gynecologists through a direct sales organization in the United Kingdom, the Netherlands, Switzerland, Belgium, Finland, Sweden, and Denmark, as well as through distributors in other markets. Cogentix Medical, Inc. was founded in 1987 and is headquartered in Minnetonka, Minnesota. http://www.priceseries.com/trade/CGNT-Cogentix-Medical-Inc-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2017072520170810.html